Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-08-05

Clinical Trial Update: Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial of Magnólia nasal gel for allergic rhinitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnólia nasal gel (Magnolia nasal gel)

Snippet

Sponsor: EMS | Conditions: Allergic Rhinitis | Phase 3 | Status: WITHDRAWN